Scipher Medicine CEO and leadership

Alison Stowell is a Chief People Officer at Scipher Medicine and is based in Waltham, Massachusetts. She has worked as Regional Staffing Consultant at Wolters Kluwer, Director Talent Management at QuantiaMD Communications, and Sr Talent Acquisition Consultant at Allergan. Alison studied at University of Massachusetts Amherst between 1989 and 1993.

Jeffrey Sachs is a Chief Legal & Compliance Officer at Scipher Medicine and is based in Waltham, Massachusetts. He has worked as Vice President and General Counsel at Outcome; Vice President & General Counsel at Outcome Sciences, Inc., a Quintiles Company; and Associate at Gesmer Updegrove LLP. Jeffrey attended Brown University and University of Virginia School of Law.

Slava Akmaev is the industry leader in AI and machine learning applications in life sciences and healthcare.He heads the Berg Analytics business division and is the chief architect of Bayesian Artificial Intelligence software, bAIcis®. Slava Akmaev is an avid advocate for data driven research and promotes wider utility of advanced mathematical modeling techniques in pharmaceutical and clinical research. Prior to his role at BERG, Slava Akmaev spent a decade at Genzyme R&D and the CLIA diagnostic laboratory, Genzyme Genetics. He led the development and commercialization of novel multi-omic panel diagnostics in oncology and prenatal medicine. Slava Akmaev has published numerous peer-reviewed manuscripts in genomics, systems biology, biochemistry and human genetics. He is a frequent speaker at AI, analytics and precision medicine conferences. Slava Akmaev holds a Ph.D. in Applied Mathematics from the University of Colorado at Boulder.

Dynamic Biotechnology Executive with two decades’ experience driving $1B+ in annual revenue in the diagnostics and pharmaceuticals industries. Global strategist with prolific D-level and C-level expertise, including leading Myriad Genetic's prostate cancer and COVID19 units and Pfizer’s state-wide primary care units in the northeast and southwest U.S. Extensive management experience ranges from scaling entrepreneurial projects to oversight of $100M+ product portfolios at Fortune 500 companies. Deep expertise on both sides of the negotiation table, proctoring deals with leading healthcare payers and pharmaceutical companies.✔ P&L leadership of $25 million diagnostics business including lab operations, customer service, product development, marketing, and sales - from launch to payer reimbursement to 300% year-over-year growth.✔ Managed $1.2 billion in annual pharmacy spend for the Regence Blue Cross Blue Shield health plans in the western U.S. generating $30M in operating income.✔ Lead 5-year strategic growth plan for top-tier genetics company encompassing 11 products in six therapeutic areas serving 2 million patients around the globe - including special projects.

Sam Asgarian is a Chief Medical Officer at Scipher Medicine and is based in Nashville, Tennessee. He has worked as VP, CMO and Product & Program Development at AETNA INC /PA/; VP, Consumer Health and Services at AETNA INC /PA/; and Executive Director and Chief of Staff at AETNA INC /PA/. Sam attended Tulane University School of Medicine between 2007 and 2012, Cornell Johnson Graduate School of Management between 2010 and 2011, and Loyola University Chicago between 2005 and 2006.